Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 367
7
Diseases
10
Unique genes
0.343
Avg. similarity score
Greither disease
Most-connected disease (6 links)
Disease
Searched: Erythrokeratodermia variabilis et progressiva 2
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Erythrokeratodermia variabilis et progressiva 2
Greither disease
Deafness, autosomal recessive
Erythrokeratoderma
Erythrokeratodermia variabilis et progressiva 1
Peripheral neuropathy with sensorineural hearing impairment syndrome
Erythrokeratodermia variabilis
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Greither disease | 6 | 6 | 4 |
| Deafness, autosomal recessive | 4 | 4 | 1 |
| Erythrokeratoderma | 4 | 4 | 1 |
| Erythrokeratodermia variabilis et progressiva 1 | 4 | 4 | 1 |
| Peripheral neuropathy with sensorineural hearing impairment syndrome | 4 | 4 | 1 |
| Erythrokeratodermia variabilis | 2 | 2 | 10 |
| Erythrokeratodermia variabilis et progressiva 2 | 2 | 2 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| GJB3 | 6 / 7 | Deafness, autosomal recessive, Erythrokeratoderma, Erythrokeratodermia variabilis, Erythrokeratodermia variabilis et progressiva 1 and 2 more |
| GJB4 | 3 / 7 | Erythrokeratodermia variabilis, Erythrokeratodermia variabilis et progressiva 2, Greither disease |
| GJA1 | 2 / 7 | Erythrokeratodermia variabilis, Greither disease |
| PERP | 2 / 7 | Erythrokeratodermia variabilis, Greither disease |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Gap junction assembly | Reactome | 3 / 18 | 200× | 3.37e-7 | 1.62e-5 ✓ sig. |
| Nef mediated downregulation of MHC class I complex cell surface expression | Reactome | 2 / 10 | 240× | 2.80e-5 | 6.85e-4 ✓ sig. |
| Lysosome Vesicle Biogenesis | Reactome | 2 / 35 | 68.6× | 3.66e-4 | 5.24e-3 ✓ sig. |
| Golgi Associated Vesicle Biogenesis | Reactome | 2 / 56 | 42.9× | 9.38e-4 | 1.08e-2 ✓ sig. |
| Regulation of gap junction activity | Reactome | 1 / 3 | 400× | 2.50e-3 | 2.23e-2 ✓ sig. |
| MHC class II antigen presentation | Reactome | 2 / 123 | 19.5× | 4.44e-3 | 3.37e-2 ✓ sig. |
| Formation of the cornified envelope | Reactome | 2 / 130 | 18.5× | 4.94e-3 | 3.64e-2 ✓ sig. |
| Lysosome | KEGG | 2 / 133 | 18.1× | 5.17e-3 | 3.73e-2 ✓ sig. |
| Formation of annular gap junctions | Reactome | 1 / 11 | 109× | 9.12e-3 | 5.37e-2 |
| Gap junction degradation | Reactome | 1 / 12 | 100× | 9.95e-3 | 5.67e-2 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | Reactome | 1 / 14 | 85.8× | 1.16e-2 | 6.22e-2 |
| Human immunodeficiency virus 1 infection | KEGG | 2 / 213 | 11.3× | 1.28e-2 | 6.60e-2 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | Reactome | 1 / 18 | 66.7× | 1.49e-2 | 7.22e-2 |
| Miscellaneous transport and binding events | Reactome | 1 / 25 | 48.0× | 2.06e-2 | 8.74e-2 |
| TRP channels | Reactome | 1 / 28 | 42.9× | 2.31e-2 | 9.30e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| basolateral protein secretion | GO:0110010 | 2 / 5 | 747× | 2.58e-6 | 1.86e-4 ✓ sig. |
| cell communication | GO:0007154 | 3 / 80 | 70.1× | 8.87e-6 | 4.95e-4 ✓ sig. |
| melanosome assembly | GO:1903232 | 2 / 19 | 197× | 4.39e-5 | 1.67e-3 ✓ sig. |
| platelet dense granule organization | GO:0060155 | 2 / 25 | 149× | 7.68e-5 | 2.54e-3 ✓ sig. |
| transmembrane transport | GO:0055085 | 4 / 557 | 13.4× | 1.42e-4 | 3.98e-3 ✓ sig. |
| cell-cell signaling | GO:0007267 | 3 / 234 | 24.0× | 2.18e-4 | 5.39e-3 ✓ sig. |
| positive regulation of atrial cardiac muscle cell action potential | GO:1903949 | 1 / 1 | 1,869× | 5.35e-4 | 9.88e-3 ✓ sig. |
| positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization | GO:1904199 | 1 / 1 | 1,869× | 5.35e-4 | 9.88e-3 ✓ sig. |
| microtubule-based transport | GO:0099111 | 1 / 1 | 1,869× | 5.35e-4 | 9.88e-3 ✓ sig. |
| 3-keto-sphinganine metabolic process | GO:0006666 | 1 / 1 | 1,869× | 5.35e-4 | 9.88e-3 ✓ sig. |
| negative regulation of gonadotropin secretion | GO:0032277 | 1 / 2 | 934× | 1.07e-3 | 1.51e-2 ✓ sig. |
| positive regulation of morphogenesis of an epithelium | GO:1905332 | 1 / 2 | 934× | 1.07e-3 | 1.51e-2 ✓ sig. |
| membrane depolarization during Purkinje myocyte cell action potential | GO:0086047 | 1 / 3 | 623× | 1.60e-3 | 1.88e-2 ✓ sig. |
| membrane depolarization during bundle of His cell action potential | GO:0086048 | 1 / 3 | 623× | 1.60e-3 | 1.88e-2 ✓ sig. |
| positive regulation of mesodermal cell differentiation | GO:1905772 | 1 / 3 | 623× | 1.60e-3 | 1.88e-2 ✓ sig. |